1. Home
  2. DRD vs XNCR Comparison

DRD vs XNCR Comparison

Compare DRD & XNCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo DRDGOLD Limited

DRD

DRDGOLD Limited

HOLD

Current Price

$26.72

Market Cap

2.5B

ML Signal

HOLD

Logo Xencor Inc.

XNCR

Xencor Inc.

HOLD

Current Price

$24.38

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DRD
XNCR
Founded
1895
1997
Country
South Africa
United States
Employees
N/A
N/A
Industry
Precious Metals
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
2.0B
IPO Year
2002
2013

Fundamental Metrics

Financial Performance
Metric
DRD
XNCR
Price
$26.72
$24.38
Analyst Decision
Strong Buy
Buy
Analyst Count
2
9
Target Price
$32.63
$22.33
AVG Volume (30 Days)
281.4K
1.3M
Earning Date
08-19-2026
05-08-2026
Dividend Yield
2.24%
N/A
EPS Growth
N/A
65.36
EPS
N/A
N/A
Revenue
N/A
$125,576,000.00
Revenue This Year
$39.23
N/A
Revenue Next Year
$30.12
$4.80
P/E Ratio
$15.32
N/A
Revenue Growth
N/A
13.65
52 Week Low
$19.47
$8.29
52 Week High
$39.37
$30.61

Technical Indicators

Market Signals
Indicator
DRD
XNCR
Relative Strength Index (RSI) 51.18 47.61
Support Level $26.37 $11.20
Resistance Level $27.25 $30.61
Average True Range (ATR) 0.84 1.60
MACD -0.39 -0.69
Stochastic Oscillator 2.28 5.48

Price Performance

Historical Comparison
DRD
XNCR

About DRD DRDGOLD Limited

DRDGold Ltd is a South African gold mining company engaged in surface gold tailings retreatment including exploration, extraction, processing, and smelting. Its reportable operating segments are; Ergo, FWGR, and Corporate office and other reconciling items. The Ergo is a surface gold retreatment operation that treats old slime dams and sand dumps to the south of Johannesburg's central business district as well as the East and Central Rand goldfields, and the FWGR which is a surface gold retreatment operation and treats old slime dams in the West Rand goldfields. The Ergo segment derives a vast majority of the company's revenue.

About XNCR Xencor Inc.

Xencor Inc is a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab and XmAb657. The group earns its revenue from collaboration agreements and licensing agreements and operates as a single reportable segment focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases who have unmet medical needs.

Share on Social Networks: